CN117625518A - Method for preparing cell culture snowflake meat - Google Patents
Method for preparing cell culture snowflake meat Download PDFInfo
- Publication number
- CN117625518A CN117625518A CN202210968300.3A CN202210968300A CN117625518A CN 117625518 A CN117625518 A CN 117625518A CN 202210968300 A CN202210968300 A CN 202210968300A CN 117625518 A CN117625518 A CN 117625518A
- Authority
- CN
- China
- Prior art keywords
- culture
- concentration
- medium
- stem cells
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013372 meat Nutrition 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 19
- 241000533950 Leucojum Species 0.000 title abstract description 7
- 238000004113 cell culture Methods 0.000 title abstract description 7
- 210000004027 cell Anatomy 0.000 claims abstract description 106
- 210000001665 muscle stem cell Anatomy 0.000 claims abstract description 71
- 230000004070 myogenic differentiation Effects 0.000 claims abstract description 53
- 239000001963 growth medium Substances 0.000 claims abstract description 44
- 210000001087 myotubule Anatomy 0.000 claims abstract description 41
- 230000004069 differentiation Effects 0.000 claims abstract description 35
- 230000009815 adipogenic differentiation Effects 0.000 claims abstract description 33
- 230000007774 longterm Effects 0.000 claims abstract description 11
- 230000001105 regulatory effect Effects 0.000 claims abstract description 6
- 239000002609 medium Substances 0.000 claims description 57
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims description 42
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 42
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 23
- 102000004877 Insulin Human genes 0.000 claims description 21
- 108090001061 Insulin Proteins 0.000 claims description 21
- 229940125396 insulin Drugs 0.000 claims description 21
- 229960004586 rosiglitazone Drugs 0.000 claims description 21
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims description 16
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 13
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 13
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 13
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 13
- 239000005642 Oleic acid Substances 0.000 claims description 13
- 239000012091 fetal bovine serum Substances 0.000 claims description 13
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 13
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 13
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 10
- 229960000905 indomethacin Drugs 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 7
- 229960003957 dexamethasone Drugs 0.000 claims description 7
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 claims description 6
- 239000012894 fetal calf serum Substances 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 239000007640 basal medium Substances 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 210000001789 adipocyte Anatomy 0.000 claims description 4
- 238000012136 culture method Methods 0.000 claims description 2
- 210000000107 myocyte Anatomy 0.000 claims description 2
- 229960002969 oleic acid Drugs 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 15
- 230000011759 adipose tissue development Effects 0.000 abstract description 8
- 230000006698 induction Effects 0.000 abstract description 8
- 230000022379 skeletal muscle tissue development Effects 0.000 abstract description 7
- 210000000130 stem cell Anatomy 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000001276 controlling effect Effects 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 32
- 150000002632 lipids Chemical class 0.000 description 27
- 102000005604 Myosin Heavy Chains Human genes 0.000 description 25
- 108010084498 Myosin Heavy Chains Proteins 0.000 description 25
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 16
- 238000010186 staining Methods 0.000 description 12
- 238000003125 immunofluorescent labeling Methods 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 238000010166 immunofluorescence Methods 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 235000013305 food Nutrition 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 235000013622 meat product Nutrition 0.000 description 3
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 230000002293 adipogenic effect Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 210000000229 preadipocyte Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1392—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from mesenchymal stem cells from other natural sources
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种细胞培养雪花肉的制造方法,属于干细胞培养及细胞培养肉技术领域。本发明公开了实现肌肉干细胞同时成肌成脂的培养基,分别可以实现肌肉干细胞的快速成肌成脂分化以及长期维持肌肉干细胞成肌成脂分化状态。本发明公开了一种利用肌肉干细胞同时产生肌纤维和脂肪的细胞培养肉制作方法,并公开了一种通过调控成肌分化能力不同的肌肉干细胞的比例,来控制细胞培养肉中脂肪和肌纤维的比例。本发明实现了在同一诱导条件下,在二维和三维培养条件中同时实现肌肉干细胞的成肌和成脂分化,无需培养多种类型细胞,即可实现培养肉中肌纤维和脂肪的同时获得,减少细胞培养的工作量,为细胞培养肉的工业化和定制化生产提供了新的思路和方法。
The invention discloses a method for manufacturing cell-cultured snowflake meat and belongs to the technical fields of stem cell culture and cell-cultured meat. The invention discloses a culture medium that realizes simultaneous myogenesis and adipogenesis of muscle stem cells, which can respectively realize rapid myogenesis and adipogenesis differentiation of muscle stem cells and long-term maintenance of myogenesis and adipogenesis differentiation state of muscle stem cells. The invention discloses a method for making cell-cultured meat that utilizes muscle stem cells to simultaneously produce muscle fibers and fat, and also discloses a method of controlling the proportion of fat and muscle fibers in cell-cultured meat by regulating the proportion of muscle stem cells with different myogenic differentiation abilities. . The present invention realizes the myogenic and adipogenic differentiation of muscle stem cells in two-dimensional and three-dimensional culture conditions under the same induction condition. It does not need to cultivate multiple types of cells and can achieve the simultaneous acquisition of muscle fibers and fat in cultured meat. Reducing the workload of cell culture provides new ideas and methods for the industrialization and customized production of cell cultured meat.
Description
技术领域Technical field
本发明涉及一种细胞培养雪花肉的制造方法,具体涉及一种可以利用肌肉干细胞同时产生肌纤维和脂肪的细胞培养雪花肉的制作方法,属于干细胞培养及细胞培养肉技术领域。The present invention relates to a method for producing cell-cultured snowflake meat. Specifically, it relates to a method for producing cell-cultured snowflake meat that can utilize muscle stem cells to simultaneously produce muscle fiber and fat. It belongs to the technical fields of stem cell culture and cell-cultured meat.
背景技术Background technique
细胞培养肉(Cultured meat)作为未来食品的重要组成部分,是根据肌肉组织的生长发育及损伤修复机理,利用体外培养动物细胞的方式,获得肌纤维、脂肪等构成肌肉组织的细胞,再经过收集、塑形、食品化加工而成的一种新型肉类食品。相比于传统肉类生产,细胞培养肉具有良好的资源转化率和可持续发展潜力,其生产过程不涉及牲畜的饲喂和宰杀,大大缩短了肉类的生产周期,同时可以提供真实的动物蛋白,必将会成为未来肉制品市场的重要组成部分。Cell cultured meat (Cultured meat), as an important part of future food, is based on the growth and development and damage repair mechanism of muscle tissue, using animal cells cultured in vitro to obtain muscle fibers, fats and other cells that make up muscle tissue, and then collect and A new type of meat food that is shaped and processed into food. Compared with traditional meat production, cell cultured meat has good resource conversion rate and sustainable development potential. Its production process does not involve the feeding and slaughtering of livestock, which greatly shortens the meat production cycle and can provide real animals. Protein will definitely become an important part of the future meat product market.
市售的肉含有肌纤维和脂肪等组织,提供了丰富的蛋白质和脂肪酸等,同时也保证了肉类制品的优质口感。细胞培养肉制作过程中,通常利用肌肉干细胞(Muscle StemCell,又称肌卫星细胞,Satellite Cell)作为种子细胞,经过体外扩增分化产生成肌细胞,再进一步分化、融合产生大量肌纤维,构成肌肉组织。但是目前,采用肌肉干细胞作为种子细胞主要用于细胞培养肌纤维的生产,若要进行细胞培养脂肪组织的制造,需要利用其他种子细胞,如间充质干细胞(Mesenchymal stem cells),造成生产工艺复杂、成本提升。如果仅采用肌肉干细胞作为种子细胞,挖掘其成脂分化能力,研发肌肉干细胞成脂分化策略,为制造同时含有肌纤维和脂肪的细胞培养雪花肉提供一种全新的方法。Commercially available meat contains tissue such as muscle fiber and fat, which provides rich protein and fatty acids, while also ensuring the high-quality taste of meat products. In the process of making cell-cultured meat, muscle stem cells (Muscle StemCell, also known as muscle satellite cells, Satellite Cell) are usually used as seed cells. They are expanded and differentiated in vitro to produce myoblasts, which are further differentiated and fused to produce a large number of muscle fibers to form muscle tissue. . However, currently, the use of muscle stem cells as seed cells is mainly used for the production of cell-cultured muscle fibers. If you want to produce cell-cultured adipose tissue, you need to use other seed cells, such as mesenchymal stem cells (Mesenchymal stem cells), resulting in a complicated production process. Cost increase. If only muscle stem cells are used as seed cells, their adipogenic differentiation ability can be explored, and the adipogenic differentiation strategy of muscle stem cells can be developed, which will provide a new method for producing cell-cultured snowflake meat containing both muscle fibers and fat.
发明内容Contents of the invention
本发明提供了一种利用肌肉干细胞同时产生肌纤维和脂肪的细胞培养肉制作方法,同时可以通过调整成肌分化能力不同的肌肉干细胞的比例,从而调控细胞培养肉中肌纤维和脂肪的比例。The invention provides a method for making cell-cultured meat that utilizes muscle stem cells to simultaneously produce muscle fibers and fat. At the same time, the ratio of muscle fibers and fat in the cell-cultured meat can be regulated by adjusting the ratio of muscle stem cells with different myogenic differentiation capabilities.
本发明的第一个目的是提供了一种快速诱导肌肉干细胞同时成肌和成脂分化的培养基,细胞可以在诱导4天后形成明显的肌管及脂滴,所述培养基的组成为(a)或(b):The first object of the present invention is to provide a culture medium that rapidly induces muscle stem cells to differentiate into myocytes and adipocytes simultaneously. The cells can form obvious myotubes and lipid droplets after 4 days of induction. The composition of the culture medium is ( a) or (b):
(a)基础培养基、胎牛血清、胰岛素、罗格列酮、油酸;(a) Basic culture medium, fetal calf serum, insulin, rosiglitazone, and oleic acid;
(b)基础培养基、马血清、罗格列酮、油酸;(b) Basic medium, horse serum, rosiglitazone, oleic acid;
在一种实施方式中,所述基础培养包括DMEM或F12。In one embodiment, the basal culture includes DMEM or F12.
在一种实施方式中,(a)中,胎牛血清使用浓度为5%(v/v),胰岛素使用浓度为1~50mg/L,罗格列酮使用浓度为1~50mg/L,油酸的使用浓度为10~300μM。In one embodiment, in (a), the concentration of fetal bovine serum is 5% (v/v), the concentration of insulin is 1-50 mg/L, the concentration of rosiglitazone is 1-50 mg/L, and the oil concentration is 5% (v/v). The acid concentration used is 10 to 300 μM.
在一种实施方式中,胰岛素的使用浓度为10mg/L,罗格列酮使用浓度为10mg/L,油酸的使用浓度为100μM。In one embodiment, the concentration of insulin is 10 mg/L, the concentration of rosiglitazone is 10 mg/L, and the concentration of oleic acid is 100 μM.
在一种实施方式中,(b)中,马血清使用浓度为2%(v/v),罗格列酮使用浓度为1~50μM,油酸的使用浓度为10~300μM。In one embodiment, in (b), the horse serum is used at a concentration of 2% (v/v), the rosiglitazone is used at a concentration of 1 to 50 μM, and the oleic acid is used at a concentration of 10 to 300 μM.
在一种实施方式中,罗格列酮使用浓度为10μM,油酸的使用浓度为100μM。In one embodiment, rosiglitazone is used at a concentration of 10 μM, and oleic acid is used at a concentration of 100 μM.
在一种实施方式中,所述肌肉干细胞包括但不限于哺乳动物或卵生动物的肌肉干细胞。In one embodiment, the muscle stem cells include, but are not limited to, mammalian or oviparous muscle stem cells.
在一种实施方式中,所述肌肉干细胞包括猪、鸡、鸭、牛或羊的肌肉干细胞。In one embodiment, the muscle stem cells comprise porcine, chicken, duck, bovine or ovine muscle stem cells.
肌肉干细胞生长至80~90%密度时更换ROI培养基或RO培养基,在37℃、5%CO2条件下培养,24小时更换一次培养基,诱导分化4天左右,能同时形成明显的肌管和脂滴。When the muscle stem cells grow to 80-90% density, replace the ROI medium or RO medium, culture at 37°C and 5% CO2 , replace the medium every 24 hours, induce differentiation for about 4 days, and form obvious muscle cells at the same time. tubes and lipid droplets.
本发明的第二目的是提供一种维持肌肉干细胞长期成肌和成脂分化的培养基,所述培养基由两部分组成:培养基A+培养基B;培养基A的组成为:基础培养基、胎牛血清、地塞米松、3-异丁基-1-甲基黄嘌(IBMX)、吲哚美辛(IDM)、胰岛素、罗格列酮;培养基B:基础培养基、胎牛血清、胰岛素。The second object of the present invention is to provide a culture medium for maintaining long-term myogenic and adipogenic differentiation of muscle stem cells. The culture medium consists of two parts: culture medium A + culture medium B; the composition of culture medium A is: basic culture medium , fetal bovine serum, dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), indomethacin (IDM), insulin, rosiglitazone; medium B: basal medium, fetal bovine Serum, insulin.
在一种实施方式中,培养基A中,胎牛血清使用浓度为10%(v/v),地塞米松使用浓度为0.1~5μM,IBMX使用浓度为1~100μM,IDM使用浓度为0.1~5μM,胰岛素使用浓度为10~300nM,罗格列酮使用浓度为1~30μM。In one embodiment, in culture medium A, the concentration of fetal bovine serum is 10% (v/v), the concentration of dexamethasone is 0.1-5 μM, the concentration of IBMX is 1-100 μM, and the concentration of IDM is 0.1-5 μM. 5 μM, insulin is used at a concentration of 10 to 300 nM, and rosiglitazone is used at a concentration of 1 to 30 μM.
在一种实施方式中,地塞米松使用浓度为1μM,IBMX使用浓度为1μM,IDM使用浓度为1μM,胰岛素使用浓度为100nM,罗格列酮使用浓度为10μM。In one embodiment, dexamethasone is used at a concentration of 1 μM, IBMX is used at a concentration of 1 μM, IDM is used at a concentration of 1 μM, insulin is used at a concentration of 100 nM, and rosiglitazone is used at a concentration of 10 μM.
在一种实施方式中,培养基B中,胎牛血清使用浓度为10%(v/v),胰岛素使用浓度为10~300nM。In one embodiment, in culture medium B, the concentration of fetal bovine serum is 10% (v/v), and the concentration of insulin is 10-300 nM.
本发明的第三个目的是提供一种维持肌肉干细胞长期成肌和成脂分化的培养方法,所述方法为利用上述维持肌肉干细胞长期成肌和成脂分化的培养基进行肌肉干细胞的分化培养。The third object of the present invention is to provide a culture method for maintaining long-term myogenic and adipogenic differentiation of muscle stem cells. The method is to use the above-mentioned culture medium for maintaining long-term myogenic and adipogenic differentiation of muscle stem cells to perform differentiation and culture of muscle stem cells. .
在一种实施方式中,所述方法为将肌肉干细胞置于普通培养基中培养至细胞密度为80~90%,更换培养基A,每24小时更换一次培养基,诱导分化3天后,更换培养基B,培养2天,循环培养3次。In one embodiment, the method is to culture muscle stem cells in a common medium until the cell density is 80-90%, replace medium A every 24 hours, induce differentiation for 3 days, and then replace the culture medium. Base B, culture for 2 days, culture cycle 3 times.
在一种实施方式中,所述普通培养基为基础培养基和10%(v/v)胎牛血清。In one embodiment, the common culture medium is basal culture medium and 10% (v/v) fetal calf serum.
在一种实施方式中,所述基础培养包括DMEM或F12。In one embodiment, the basal culture includes DMEM or F12.
在一种实施方式中,所述方法的培养条件为在37℃、5%CO2。In one embodiment, the culture conditions of the method are at 37°C, 5% CO2 .
本发明的第四个目的是提供了一种调控细胞培养肉中脂肪和肌纤维比例的方法,将不同代数的肌肉干细胞按照一定比例混合,于上述培养基快速诱导肌肉干细胞同时成肌和成脂分化的培养基或上述维持肌肉干细胞长期成肌和成脂分化的培养基中进行成肌和成脂分化培养。The fourth object of the present invention is to provide a method for regulating the proportion of fat and muscle fiber in cell cultured meat. Muscle stem cells of different generations are mixed according to a certain ratio, and the muscle stem cells are rapidly induced to differentiate into myogenesis and adipogenesis simultaneously in the above culture medium. The myogenic and adipogenic differentiation culture is performed in the medium or the above-mentioned medium that maintains long-term myogenic and adipogenic differentiation of muscle stem cells.
本发明还提供了上述快速诱导肌肉干细胞同时成肌和成脂分化的培养基或上述维持肌肉干细胞长期成肌和成脂分化的培养基在细胞培养肉领域的应用。The present invention also provides the application of the above-mentioned medium for rapidly inducing simultaneous myogenic and adipogenic differentiation of muscle stem cells or the above-mentioned medium for maintaining long-term myogenic and adipogenic differentiation of muscle stem cells in the field of cell cultured meat.
有益效果:Beneficial effects:
肌内前体脂肪细胞和肌肉干细胞(也称肌卫星细胞)是两种不同的细胞,肌内前体脂肪细胞主要定向分化为脂肪组织,肌肉干细胞则具有多能性,具有分化为肌纤维、脂肪、骨等潜力;制作细胞培养肉需要肌纤维、脂肪等组织构成,通常需要单独培养2种或以上细胞并分别诱导或共培养才可形成同时含有肌纤维和脂肪,但因为肌肉干细胞具有多向分化的潜力,所以本发明在诱导脂肪细胞成脂培养的培养基基础上优化并运用于肌肉干细胞上,使其可以同时成肌成脂,达到仅用一种细胞同时产生肌纤维和脂肪的作用。Intramuscular preadipocytes and muscle stem cells (also called muscle satellite cells) are two different types of cells. Intramuscular preadipocytes mainly differentiate into adipose tissue, while muscle stem cells are pluripotent and have the ability to differentiate into muscle fibers and fat. , bone and other potential; making cell-cultured meat requires muscle fiber, fat and other tissue components. Usually, two or more types of cells need to be cultured separately and induced or co-cultured separately to form a cell that contains both muscle fiber and fat. However, because muscle stem cells have the ability to differentiate in multiple directions Potential, so the present invention optimizes and applies it to muscle stem cells based on the culture medium for inducing adipocyte adipogenesis, so that it can form muscle and adipocytes at the same time, achieving the effect of using only one type of cells to produce muscle fibers and fat at the same time.
本发明确定了三种可以实现肌肉干细胞同时成肌成脂的培养基,分别可以实现肌肉干细胞的快速成肌成脂分化以及长期维持肌肉干细胞成肌成脂分化状态。同时发现体外培养不同时间肌肉干细胞的成肌分化和成脂分化能力不同,体外培养时间较短的细胞成肌分化能力更强,培养时间较长的细胞能够获得更多的脂肪,因此可以通过调控培养肉中成肌分化能力不同的肌肉干细胞的比例,来控制细胞培养肉中脂肪和肌纤维的比例。可以在同一诱导条件下同时实现肌肉干细胞的成肌和成脂分化,无需培养多种类型细胞,即可实现培养肉中肌纤维和脂肪的同时获得,大大减少了培养细胞的工作量,为细胞培养肉的工业化和定制化生产提供了一个新的思路和方法。The present invention identifies three culture media that can achieve simultaneous myogenesis and adipogenesis of muscle stem cells, which can respectively achieve rapid myogenesis and adipogenesis differentiation of muscle stem cells and long-term maintenance of the myogenesis and adipogenesis differentiation state of muscle stem cells. At the same time, it was found that muscle stem cells have different myogenic and adipogenic differentiation abilities at different times cultured in vitro. Cells cultured for a shorter time in vitro have stronger myogenic differentiation ability, and cells cultured for a longer time can obtain more fat. Therefore, they can be regulated through regulation. The proportion of muscle stem cells with different myogenic differentiation abilities in cultured meat is used to control the proportion of fat and muscle fibers in cell cultured meat. Myogenic and adipogenic differentiation of muscle stem cells can be achieved simultaneously under the same induction conditions. Without culturing multiple types of cells, muscle fibers and fat in cultured meat can be obtained at the same time, which greatly reduces the workload of culturing cells and provides better conditions for cell culture. The industrialized and customized production of meat provides a new idea and method.
附图说明Description of drawings
图1为P4代细胞成肌分化组、ROI组和RO组不同培养时间的细胞形态(4×视野);Figure 1 shows the cell morphology of P4 generation cells in myogenic differentiation group, ROI group and RO group at different culture times (4× visual field);
图2为P4代细胞成肌分化组、ROI组和RO组培养4天油红O染色情况;Figure 2 shows the Oil Red O staining of P4 generation cells in myogenic differentiation group, ROI group and RO group after 4 days of culture;
图3为P4代细胞成肌分化组、ROI组和RO组培养4天后产生脂滴及肌纤维的细胞比例;Figure 3 shows the proportion of cells producing lipid droplets and muscle fibers in the P4 generation cell myogenic differentiation group, ROI group and RO group after culture for 4 days;
图4为P4代细胞成肌分化组、ROI组和RO组培养4天MyHC免疫荧光染色情况;Figure 4 shows the MyHC immunofluorescence staining of P4 generation cells in myogenic differentiation group, ROI group and RO group after 4 days of culture;
图5为P4代细胞成肌分化组、成肌成脂分化组不同培养时间的细胞形态(4×视野);Figure 5 shows the cell morphology of the P4 generation cells in the myogenic differentiation group and myoadipogenic differentiation group at different culture times (4×field of view);
图6为P4代细胞成肌分化组、成肌成脂分化组第4天和第10天油红O染色情况;Figure 6 shows the Oil Red O staining on days 4 and 10 of the myogenic differentiation group and myoadipogenic differentiation group of P4 generation cells;
图7为P4代细胞成肌分化组、成肌成脂分化组第4天和第10天MyHC免疫荧光染色情况;Figure 7 shows the MyHC immunofluorescence staining on days 4 and 10 in the myogenic differentiation group and myoadipogenic differentiation group of P4 generation cells;
图8为不同代数细胞在不同培养条件下培养4天油红O染色情况(20×视野);Figure 8 shows the Oil Red O staining of cells of different generations under different culture conditions for 4 days (20× visual field);
图9为不同代数细胞在不同培养条件下培养4天MyHC免疫荧光染色情况(10×视野);Figure 9 shows the MyHC immunofluorescence staining of cells of different passages cultured under different culture conditions for 4 days (10× field of view);
图10为不同代数细胞在不同培养条件下培养4天后产生脂滴的细胞比例;Figure 10 shows the proportion of cells producing lipid droplets after cells of different passages were cultured under different culture conditions for 4 days;
图11为不同代数细胞在不同培养条件下培养4天后形成肌纤维的细胞比例;Figure 11 shows the proportion of cells that formed muscle fibers after cells of different passages were cultured under different culture conditions for 4 days;
图12为不同代数细胞在不同培养条件下形成脂肪与肌纤维的细胞比例。Figure 12 shows the proportion of cells forming fat and muscle fibers in different passages of cells under different culture conditions.
具体实施方式Detailed ways
下述实施例中涉及到的培养基:Culture media involved in the following examples:
基础培养基(按体积百分比):90%DMEM培养基、10%胎牛血清(FBS)。Basal medium (by volume percentage): 90% DMEM medium, 10% fetal bovine serum (FBS).
分化培养基(按体积百分比):98%DMEM培养基、2%马血清。Differentiation medium (by volume percentage): 98% DMEM medium, 2% horse serum.
ROI培养基(按体积百分比):95%DMEM培养基、5%胎牛血清、10mg/L胰岛素、10mg/L罗格列酮、100μM油酸。ROI medium (by volume percentage): 95% DMEM medium, 5% fetal calf serum, 10 mg/L insulin, 10 mg/L rosiglitazone, 100 μM oleic acid.
RO培养基(按体积百分比):98%DMEM培养基、2%马血清、10μM罗格列酮、100μM油酸。RO medium (by volume percentage): 98% DMEM medium, 2% horse serum, 10 μM rosiglitazone, 100 μM oleic acid.
LMF培养基(由A和B组成):培养基A(按体积百分比):90%DMEM、10%胎牛血清、1μM地塞米松、1μM 3-异丁基-1-甲基黄嘌(IBMX)、1μM吲哚美辛(IDM)、100nM胰岛素、10μM罗格列酮;培养基B(按体积百分比):90%DMEM、10%胎牛血清、100nM胰岛素。LMF medium (composed of A and B): Medium A (by volume percentage): 90% DMEM, 10% fetal calf serum, 1 μM dexamethasone, 1 μM 3-isobutyl-1-methylxanthine (IBMX ), 1 μM indomethacin (IDM), 100 nM insulin, 10 μM rosiglitazone; medium B (by volume percentage): 90% DMEM, 10% fetal bovine serum, 100 nM insulin.
下述实施例中涉及到的实验方法:Experimental methods involved in the following examples:
1、油红O染色:油红O是很强的脂溶剂和染脂剂,较易和甘油三脂结合呈小脂滴状,因其在细胞内脂质的溶解度较原溶剂中的溶解度更大,从而进行脂肪染色。具体操作如下:1. Oil Red O staining: Oil Red O is a strong lipid solvent and lipid dye. It is easier to combine with triglycerides to form small lipid droplets because its solubility in intracellular lipids is higher than in the original solvent. Large for fat staining. The specific operations are as follows:
(1)染色前,吸去培养皿中的培养基,使用PBS清洗2-3遍;(1) Before staining, aspirate the culture medium in the culture dish and wash it 2-3 times with PBS;
(2)使用4%多聚甲醛室温下避光固定10min;(2) Use 4% paraformaldehyde to fix for 10 minutes at room temperature in the dark;
(3)去除废液,添加新的4%多聚甲醛避光固定1h后,使用PBS清洗2-3遍;(3) Remove the waste liquid, add new 4% paraformaldehyde and fix in the dark for 1 hour, then wash 2-3 times with PBS;
(4)将贮备液与稀释液按照5:2的比例混合,过滤去除杂质。添加适量染液恰好覆盖细胞层,37℃下染色10-15min,使用PBS清洗5-20s;(4) Mix the stock solution and diluent in a ratio of 5:2, and filter to remove impurities. Add an appropriate amount of dye solution to cover the cell layer, stain at 37°C for 10-15 minutes, and wash with PBS for 5-20 seconds;
(5)使用复染液染色3-5min,使用PBS清洗30-60s;(5) Stain with counterstain solution for 3-5 minutes and wash with PBS for 30-60 seconds;
(6)在显微镜下进行细胞观察,脂肪为红色,细胞核为深蓝色。(6) Observe cells under a microscope. Fat is red and cell nuclei are dark blue.
油红O染液试剂盒购于南京建成生物工程研究所有限公司。Oil Red O stain kit was purchased from Nanjing Jiancheng Bioengineering Research Institute Co., Ltd.
2、免疫荧光鉴定:2. Immunofluorescence identification:
(1)吸去待处理孔的培养基,用PBS缓冲液小心清洗2次,洗去大部分未贴壁细胞;(1) Aspirate the culture medium from the wells to be treated and carefully wash twice with PBS buffer to remove most of the non-adherent cells;
(2)用150μL 4%多聚甲醛(4℃预冷)固定,室温下通透15min后除去多聚甲醛,用PBS缓冲液小心清洗3次;(2) Fix with 150 μL 4% paraformaldehyde (pre-cooled at 4°C), permeate for 15 minutes at room temperature, remove the paraformaldehyde, and wash carefully three times with PBS buffer;
(3)加入150μL含有0.5%TritonX-100的PBS处理15min后,去除溶液,用PBS缓冲液小心清洗3次;(3) Add 150 μL of PBS containing 0.5% TritonX-100 and treat for 15 minutes, then remove the solution and wash carefully 3 times with PBS buffer;
(4)加150μL封闭液(1%BSA、含终浓度22.52mg/mL甘氨酸的PBST;PBST为含0.1%Tween20的PBS),室温孵育30min;去除溶液,用PBS缓冲液小心清洗3次;(4) Add 150 μL blocking solution (1% BSA, PBST containing final concentration 22.52 mg/mL glycine; PBST is PBS containing 0.1% Tween20), and incubate at room temperature for 30 minutes; remove the solution and wash carefully three times with PBS buffer;
(5)加入在含有1%牛血清白蛋白(BSA)的PBS中稀释的MyHC抗体100μL,用锡箔纸包被后室温孵育1h后4℃过夜;(5) Add 100 μL of MyHC antibody diluted in PBS containing 1% bovine serum albumin (BSA), cover with tin foil, incubate at room temperature for 1 hour and then overnight at 4°C;
(6)过夜处理后,放至室温1h后,用PBS清洗3次,每次5min。加入在含有1%BSA的PBS溶液中1:200稀释的荧光标记的二抗100μL,用锡箔纸包住后,室温孵育1-1.5h。(6) After overnight treatment, let it come to room temperature for 1 hour, then wash with PBS 3 times, 5 minutes each time. Add 100 μL of fluorescently labeled secondary antibody diluted 1:200 in PBS solution containing 1% BSA, wrap it with tin foil, and incubate at room temperature for 1-1.5 h.
(7)用PBS洗三次,加入20μM DAPI 100μL,室温避光孵育10min,用PBS洗三次,每次5min,加入100μL PBS。在荧光显微镜下观察拍照。(7) Wash three times with PBS, add 100 μL of 20 μM DAPI, incubate at room temperature for 10 min in the dark, wash three times with PBS, 5 min each time, and add 100 μL of PBS. Observe and take pictures under a fluorescence microscope.
实施例1快速诱导肌肉干细胞同时成肌和成脂分化Example 1 Rapid induction of simultaneous myogenic and adipogenic differentiation of muscle stem cells
将具有分化潜能的原代肌肉干细胞(体外培养第4代,P4)分别以104细胞/孔接种至96孔板中,分别设置成肌分化组、ROI组和RO组,每组均设置3个平行。先在基础培养基中37℃、5%CO2条件下培养使肌肉干细胞贴壁,待细胞密度长至80~90%时,分别更换分化培养基、ROI培养基和RO培养基。Primary muscle stem cells with differentiation potential (4th passage cultured in vitro, P4) were seeded into 96-well plates at 10 4 cells/well, and myogenic differentiation groups, ROI groups and RO groups were set up respectively. Each group was set to 3 A parallel. First, culture the muscle stem cells in the basal medium at 37°C and 5% CO2 to adhere to the wall. When the cell density reaches 80-90%, the differentiation medium, ROI medium and RO medium are replaced respectively.
每24小时更换一次培养基,每天在显微镜下进行观察和拍照,待分化培养至第4天时,进行油红O染色及肌球蛋白重链(MyHC)免疫荧光染色,分别考察各组脂滴及MyHC的生成情况。The culture medium was changed every 24 hours, and observations and photos were taken under a microscope every day. When the differentiation culture reached the 4th day, Oil Red O staining and myosin heavy chain (MyHC) immunofluorescence staining were performed to examine the lipid droplets and lipid droplets of each group. The generation of MyHC.
成肌分化组、ROI组和RO组不同培养时间的细胞形态如图1所示,分化培养第4天时油红O染色情况如图2所示,MyHC免疫荧光染色情况如图3所示。可以看出在分化培养第一天时三组细胞生长情况相似(图1),随着诱导时间增加,三组培养条件下的肌肉干细胞都能够明显分化形成多核肌管,在ROI组和RO组还能有明显聚团细胞存在(图1)。第4天油红O结果及产生脂滴细胞比例显示,成肌分化组细胞仅存在少量红色油滴于肌管附近,ROI组和RO组出现显著脂滴,与肌管并列存在,且ROI组脂滴更加明显,ROI组产生脂滴细胞比例比成肌分化组高出30%左右(图2,图3)。MyHC免疫荧光及产生肌纤维细胞比例结果显示,三组培养条件下,肌肉干细胞均可以形成多核肌管,表达MyHC蛋白,因此确定在ROI组和RO组中肌肉干细胞可以快速、同时产生肌纤维及脂肪,在诱导4天左右即可形成(图3,图4)。The cell morphology of the myogenic differentiation group, ROI group and RO group at different culture times is shown in Figure 1, the Oil Red O staining on the 4th day of differentiation and culture is shown in Figure 2, and the MyHC immunofluorescence staining is shown in Figure 3. It can be seen that the growth conditions of the three groups of cells were similar on the first day of differentiation and culture (Figure 1). As the induction time increased, the muscle stem cells in the three groups of culture conditions were able to significantly differentiate to form multinucleated myotubes. In the ROI group and RO group, There are also obvious aggregated cells (Figure 1). The Oil Red O results and the proportion of cells producing lipid droplets on the 4th day showed that there were only a small amount of red oil droplets near the myotubes in the cells of the myogenic differentiation group. Significant lipid droplets appeared in the ROI group and RO group, existing side by side with the myotubes, and in the ROI group Lipid droplets were more obvious, and the proportion of cells producing lipid droplets in the ROI group was about 30% higher than that in the myogenic differentiation group (Figure 2, Figure 3). The results of MyHC immunofluorescence and the proportion of myofiber-producing cells show that under the three groups of culture conditions, muscle stem cells can form multinucleated myotubes and express MyHC protein. Therefore, it is determined that muscle stem cells can quickly and simultaneously produce muscle fibers and fat in the ROI group and RO group. It can be formed in about 4 days of induction (Figure 3, Figure 4).
将ROI培养基中胰岛素浓度调整至1~50mg/L,罗格列酮浓度调整至1~50mg/L,油酸浓度调整至10~300μM;将RO培养基中罗格列酮的浓度调整至1~50μM,油酸浓度调整至10~300μM,按照相同的方法诱导肌肉干细胞成肌及成脂分化,均可实现肌纤维和脂肪的同时形成。Adjust the concentration of insulin in the ROI medium to 1 to 50 mg/L, the concentration of rosiglitazone to 1 to 50 mg/L, and the concentration of oleic acid to 10 to 300 μM; adjust the concentration of rosiglitazone in the RO medium to 1 to 50 μM, adjust the oleic acid concentration to 10 to 300 μM, and induce myogenic and adipogenic differentiation of muscle stem cells according to the same method, which can achieve the simultaneous formation of muscle fibers and fat.
实施例2肌肉干细胞长期稳定成肌成脂分化Example 2 Long-term stable myogenic and adipogenic differentiation of muscle stem cells
将具有分化潜能的原代肌肉干细胞(体外培养第4代,P4)分别以104细胞/孔接种至96孔板中,分别设置成肌分化组、成肌成脂分化组,每组均设置3个平行,先在基础培养基中37℃、5%CO2条件下培养使肌肉干细胞贴壁,待细胞密度长至80~90%时,分别更换分化培养基、LMF培养基(由A和B组成)。Primary muscle stem cells with differentiation potential (the 4th passage cultured in vitro, P4) were seeded into 96-well plates at 10 4 cells/well, and myogenic differentiation groups and myoadipogenic differentiation groups were set up respectively. Each group was set 3 parallels were performed. First, culture the muscle stem cells in the basic medium at 37°C and 5% CO2 to allow the muscle stem cells to adhere to the wall. When the cell density reaches 80-90%, the differentiation medium and LMF medium (composed of A and B composition).
成肌成脂分化组的肌肉干细胞生长至80~90%密度时更换培养基A,在37℃、5%CO2条件下培养,诱导分化3天后,更换培养基B,在37℃、5%CO2条件下培养2天,如此共循环培养3次,能长期维持肌管及脂滴形态,脂滴随培养时间增长逐渐变多。When the muscle stem cells in the myogenic and adipogenic differentiation group grow to a density of 80-90%, medium A is replaced and cultured at 37°C and 5% CO2 . After inducing differentiation for 3 days, medium B is replaced and cultured at 37°C and 5% CO2. Culturing for 2 days under CO2 conditions, and culturing in this cycle for a total of 3 times, can maintain the morphology of myotubes and lipid droplets for a long time, and the number of lipid droplets gradually increases as the culture time increases.
两组细胞每24小时更换一次培养基,每天在显微镜下进行观察和拍照,待培养至第4天和第10天时,进行油红O染色及肌球蛋白重链(MyHC)免疫荧光染色,分别考察各组脂滴及MyHC的生成情况。The culture medium of the two groups of cells was changed every 24 hours, and they were observed and photographed under a microscope every day. On the 4th and 10th days of culture, Oil Red O staining and myosin heavy chain (MyHC) immunofluorescence staining were performed, respectively. The formation of lipid droplets and MyHC in each group was examined.
成肌分化组、成肌成脂分化组不同培养时间的细胞形态如图5所示,第4天和第10天油红O染色情况如图6所示,MyHC免疫荧光染色情况如图7所示。可以看出在培养第1天时两组细胞生长情况相似,培养至第3天,两种培养条件下肌肉干细胞都能形成明显的多核肌管,但在第6天后,成肌分化组细胞出现明显脱落情况,随着培养时间增长细胞掉落情况更加严重,但在成肌成脂分化组,培养至第10天细胞也未有明显脱落,可以很好的生存和贴壁(图5)。第4天和第10天油红O结果显示,成肌分化组细胞仅存在少量红色油滴于肌管附近,且随着培养时间增长,脂滴含量并未明显增加,并且伴随细胞脱落的情况;成肌成脂分化组细胞在第4和第10天贴壁能力均很好,未见细胞明显脱落,同时产生的脂滴含量明显多于成肌分化组,随着培养时间增长,脂肪含量逐渐增加(图6)。MyHC免疫荧光结果显示,两种培养条件下,肌肉干细胞均可以形成多核肌管,表达MyHC蛋白,但在第10天成肌分化组产生的肌管存在明显脱落情况,成肌成脂分化组肌管仍能很好贴附(图7)。因此确定LMF培养基可以大大延长肌肉干细胞在分化培养条件下的细胞的存活时间,且同时产生肌纤维和脂肪,适用于肌肉干细胞的二维和三维培养。The cell morphology of the myogenic differentiation group and the myoadipogenic differentiation group at different culture times is shown in Figure 5, the Oil Red O staining on the 4th and 10th days is shown in Figure 6, and the MyHC immunofluorescence staining is shown in Figure 7 Show. It can be seen that the growth conditions of the two groups of cells were similar on the first day of culture. By the third day of culture, muscle stem cells could form obvious multinucleated myotubes under both culture conditions. However, after the sixth day, the cells in the myogenic differentiation group showed obvious As for the cell shedding, the cell shedding became more serious as the culture time increased. However, in the myogenic and adipogenic differentiation group, the cells did not fall off significantly until the 10th day of culture, and they could survive and adhere well (Figure 5). The Oil Red O results on days 4 and 10 showed that cells in the myogenic differentiation group only had a small amount of red oil droplets near the myotubes, and as the culture time increased, the content of lipid droplets did not increase significantly, and cells were shed. ; The adhesion ability of the cells in the myogenic and adipogenic differentiation group was very good on the 4th and 10th days, and no cells were obviously shed. At the same time, the content of lipid droplets produced was significantly more than that in the myogenic differentiation group. As the culture time increased, the fat content increased. gradually increased (Figure 6). MyHC immunofluorescence results showed that under both culture conditions, muscle stem cells could form multinucleated myotubes and express MyHC protein. However, on the 10th day, the myotubes produced in the myogenic differentiation group had obvious shedding, and the myotubes in the myoadipogenic differentiation group It still adheres well (Figure 7). Therefore, it was determined that LMF culture medium can greatly extend the survival time of muscle stem cells under differentiation culture conditions and produce muscle fibers and fat at the same time. It is suitable for two-dimensional and three-dimensional culture of muscle stem cells.
将LMF A培养基中地塞米松使用浓度调整为0.1~5μM,IBMX使用浓度调整为1~100μM,IDM使用浓度调整为0.1~5μM,胰岛素使用浓度调整为10~300nM,罗格列酮使用浓度调整为1~30μM;将LMF B培养基中的胰岛素使用浓度调整为10~300nM,按照相同的方法诱导肌肉干细胞陈及成脂分化,均可实现肌纤维和脂肪的同时形成。Adjust the concentration of dexamethasone in LMF A medium to 0.1-5 μM, the concentration of IBMX to 1-100 μM, the concentration of IDM to 0.1-5 μM, the concentration of insulin to 10-300 nM, and the concentration of rosiglitazone. Adjust the concentration of insulin in LMF B medium to 10 to 30 μM; adjust the concentration of insulin in LMF B medium to 10 to 300 nM, and induce muscle stem cell aging and adipogenic differentiation according to the same method, which can achieve the simultaneous formation of muscle fibers and fat.
实施例3测定不同代数肌肉干细胞成肌成脂分化的能力Example 3 Determining the myogenic and adipogenic differentiation abilities of muscle stem cells at different generations
不同代数的肌肉干细胞其成肌成脂能力不同,分别选取具有分化潜能的P4代肌肉干细胞(体外培养第4代,P4)和代数靠后的P8代肌肉干细胞(体外培养第8代,P8)来考察其成肌成脂能力的变化。分别将P4代和P8代细胞接种至96孔板中,分别设置成肌分化组、成肌成脂分化组、ROI组和RO组,每组均设置3个平行,在基础培养基中使肌肉干细胞伸展,在37℃、5%CO2条件下培养2~3天后,分别更换肌肉干细胞分化培养基、LMF培养基、ROI培养基和RO培养基。分化培养基、ROI培养基和RO培养基每24小时更换一次。成肌成脂分化组按照LMF培养基中的培养基A培养3天后更换培养基B培养2天的方式,循环培养3次,每24小时更换一次。每天进行观察和拍照,待培养至第4天和第10天时,对96孔板细胞进行油红O染色及肌球蛋白重链(MyHC)免疫荧光染色,分别考察各组脂滴及MyHC的生成情况,计算产生脂肪的细胞比例及形成肌纤维的细胞比例。Muscle stem cells of different generations have different myogenic and adipogenic abilities. P4 generation muscle stem cells with differentiation potential (4th generation cultured in vitro, P4) and P8 generation muscle stem cells with lower generations (8th generation cultured in vitro, P8) were selected. To examine the changes in its muscle-forming and lipogenic abilities. P4 and P8 generation cells were seeded into 96-well plates respectively, and myogenic differentiation group, myoadipogenic differentiation group, ROI group and RO group were set up respectively. Each group was set up in 3 parallel groups. The muscles were cultured in basal medium. The stem cells were stretched and cultured at 37°C and 5% CO2 for 2 to 3 days, and then the muscle stem cell differentiation medium, LMF medium, ROI medium and RO medium were replaced respectively. Differentiation medium, ROI medium and RO medium were replaced every 24 hours. In the myogenic and adipogenic differentiation group, culture medium A in LMF medium was cultured for 3 days and then culture medium B was replaced for 2 days. The culture was cycled 3 times and replaced every 24 hours. Observations and photos were taken every day. On the 4th and 10th days of culture, cells in 96-well plates were stained with Oil Red O and immunofluorescence staining with myosin heavy chain (MyHC) to examine the production of lipid droplets and MyHC in each group. situation, calculate the proportion of cells that produce fat and the proportion of cells that form muscle fibers.
P4代和P8代细胞成肌分化组、成肌成脂分化组、ROI组和RO组培养4天后油红O染色情况如图8所示,MyHC免疫荧光染色情况如图9所示,产生脂滴的细胞比例如图10所示,形成肌纤维的细胞比例如图11所示,形成脂肪与肌纤维的细胞比例如图12所示。The oil red O staining of the P4 and P8 generation cells in the myogenic differentiation group, myoadipogenic differentiation group, ROI group and RO group after culture for 4 days is shown in Figure 8, and the MyHC immunofluorescence staining is shown in Figure 9. Lipid production The proportion of cells in the drop is shown in Figure 10, the proportion of cells forming muscle fibers is shown in Figure 11, and the proportion of cells forming fat and muscle fibers is shown in Figure 12.
第4天油红O结果及产生脂滴的细胞比例分析,成肌分化组无明显聚团脂滴产生,成肌成脂分化组、ROI组和RO组细胞均产生明显脂滴(图8),且P8代细胞产生脂滴的细胞比例较P4代细胞更高,ROI组具有最多的产脂细胞(图10)。MyHC免疫荧光结果及形成肌纤维的细胞比例分析,在4种培养条件下,P4代细胞在4种条件下均能较好分化,可以明显形成多核肌管,P8代细胞各组培养条件下均无明显肌管生成,无明显MyHC蛋白荧光(图9),比例均在10%以下,说明P8代细胞成肌分化能力已经很弱,各组间无显著差异(图11)。从不同代数细胞在不同培养条件下形成脂肪与肌纤维的细胞比例结果中可以看出,P4代细胞产生肌纤维更多,P8代细胞具有更高的脂肪/肌纤维比例,在培养4天时,ROI组具有最高比例(图12)。Analysis of the Oil Red O results and the proportion of cells producing lipid droplets on day 4 showed that no obvious aggregation of lipid droplets was produced in the myogenic differentiation group, while cells in the myogenic and adipogenic differentiation groups, ROI group and RO group all produced obvious lipid droplets (Figure 8) , and the proportion of cells producing lipid droplets in P8 generation cells was higher than that in P4 generation cells, and the ROI group had the most lipid-producing cells (Figure 10). MyHC immunofluorescence results and analysis of the proportion of cells forming myofibers showed that under four culture conditions, P4 generation cells could differentiate well under four conditions and could clearly form multinucleated myotubes, while P8 generation cells did not differentiate under each group of culture conditions. There was obvious myotube formation, but there was no obvious MyHC protein fluorescence (Figure 9), and the proportions were all below 10%, indicating that the myogenic differentiation ability of P8 generation cells was already very weak, and there was no significant difference between the groups (Figure 11). It can be seen from the results of the ratio of cells that form fat to muscle fibers in different generations of cells under different culture conditions that P4 generation cells produce more muscle fibers, and P8 generation cells have a higher fat/muscle fiber ratio. When cultured for 4 days, the ROI group has The highest ratio (Figure 12).
本实例结果说明,不同代数细胞的成肌分化和成脂分化能力存在显著差异,靠前代数细胞分化能力较强,可以产生较多肌纤维,靠后代数细胞成肌分化减弱,但在成脂分化培养基诱导下,仍可保持较好成脂分化能力,可以产生脂肪。The results of this example show that there are significant differences in the myogenic differentiation and adipogenic differentiation capabilities of cells of different generations. The differentiation ability of cells in the early generations is stronger and can produce more muscle fibers. The myogenic differentiation of cells in later generations is weakened, but in the adipogenic differentiation Under the induction of culture medium, it can still maintain good adipogenic differentiation ability and can produce fat.
实施例4不同脂肪/肌纤维比例的细胞培养雪花肉制作Example 4 Preparation of cell cultured snowflake meat with different fat/muscle fiber ratios
不同代数细胞的成肌分化和成脂分化能力存在显著差异,靠前代数细胞分化能力较强,可以产生较多肌纤维,靠后代数细胞成肌分化减弱,但在成脂分化培养基诱导下,仍可保持较好成脂分化能力,可以产生脂肪。因此可以通过控制分化能力不同的细胞的比例,在成肌成脂培养基条件下进行诱导分化,从而调控脂肪与肌纤维的比例,为定制化、个性化的细胞培养肉生产提供新的思路。There are significant differences in the myogenic differentiation and adipogenic differentiation abilities of cells of different generations. The differentiation ability of cells of earlier generations is stronger and can produce more muscle fibers, while the myogenic differentiation of cells of later generations is weakened. However, under the induction of adipogenic differentiation medium, It can still maintain good adipogenic differentiation ability and can produce fat. Therefore, it is possible to control the proportion of cells with different differentiation capabilities and induce differentiation under myogenic and adipogenic medium conditions, thereby regulating the proportion of fat and muscle fibers, and providing new ideas for customized and personalized cell-cultured meat production.
培养细胞为成肌分化能力较强的P3代肌肉干细胞(体外培养第3代,P3)和成脂分化能力较强的P8代肌肉干细胞(体外培养第8代,P8),设置3个组别,其P3/P8比例分别为4:1,1:1,1:4,将三组细胞按照比例混合后分别与纤维蛋白原水凝胶(10mg/mL)混合均匀,使其初始细胞浓度为2×106个/mL,接种于96孔板中,每孔40-60μL,水凝胶完全成胶凝固后,加入200μL含10%FBS的DMEM培养基使细胞伸展。于37℃、5%CO2的细胞培养箱中培养48h,吸去培养基,加入200μL LMF培养基进行分化培养,每24h更换一次LMF培养基,于37℃、5%CO2的细胞培养箱中培养10天。每天进行观察和拍照,待分化培养至第4天和第10天时,对96孔板细胞进行油红O染色及肌球蛋白重链(MyHC)免疫荧光染色,分别考察各组脂滴及MyHC的生成情况,在水凝胶中取相同厚度片层固定染色,计算产生脂肪的细胞比例及形成肌纤维的细胞比例。可以见到三组中脂肪与肌纤维比例不同,从而得到不同脂肪/肌纤维比例的细胞培养雪花肉产品。The cultured cells are P3 generation muscle stem cells with strong myogenic differentiation ability (3rd generation cultured in vitro, P3) and P8 generation muscle stem cells with strong adipogenic differentiation ability (8th generation cultured in vitro, P8). Three groups are set up. , the P3/P8 ratios are 4:1, 1:1, 1:4 respectively. Mix the three groups of cells according to the proportion and mix them with fibrinogen hydrogel (10mg/mL) evenly, so that the initial cell concentration is 2 ×10 6 cells/mL, inoculate into a 96-well plate, 40-60 μL per well. After the hydrogel is completely gelled and solidified, add 200 μL of DMEM medium containing 10% FBS to allow the cells to stretch. Cultivate in a cell culture incubator at 37°C and 5% CO2 for 48 hours. Aspirate the medium and add 200 μL LMF medium for differentiation culture. Replace the LMF medium every 24 hours and incubate in a cell culture incubator at 37°C and 5% CO2. Culture for 10 days. Observations and photos were taken every day. When the differentiation culture reached the 4th and 10th days, Oil Red O staining and myosin heavy chain (MyHC) immunofluorescence staining were performed on the cells in the 96-well plate to examine the lipid droplets and MyHC in each group. To determine the production situation, take slices of the same thickness in the hydrogel, fix and stain them, and calculate the proportion of cells that produce fat and the proportion of cells that form muscle fibers. It can be seen that the proportions of fat and muscle fibers in the three groups are different, thus obtaining cell cultured snowflake meat products with different fat/muscle fiber ratios.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above in terms of preferred embodiments, they are not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, The protection scope of the present invention should be defined by the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210968300.3A CN117625518B (en) | 2022-08-12 | 2022-08-12 | Method for preparing cell culture snowflake meat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210968300.3A CN117625518B (en) | 2022-08-12 | 2022-08-12 | Method for preparing cell culture snowflake meat |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117625518A true CN117625518A (en) | 2024-03-01 |
CN117625518B CN117625518B (en) | 2025-01-03 |
Family
ID=90020407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210968300.3A Active CN117625518B (en) | 2022-08-12 | 2022-08-12 | Method for preparing cell culture snowflake meat |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117625518B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118497112A (en) * | 2024-04-30 | 2024-08-16 | 江南大学 | Food-grade adipogenic differentiation inducer for cell-cultured meat |
CN118530938A (en) * | 2024-07-26 | 2024-08-23 | 吉林大学 | An optimized method for promoting adipogenic differentiation of bovine skeletal muscle cells |
CN119020275A (en) * | 2024-10-29 | 2024-11-26 | 中国海洋大学 | Marine fish cell culture fish oil and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040038249A1 (en) * | 2001-08-02 | 2004-02-26 | Raphael Darteil | Inducible expression systems employing PPAR transcriptional activators |
US6835390B1 (en) * | 2000-11-17 | 2004-12-28 | Jon Vein | Method for producing tissue engineered meat for consumption |
CN107254434A (en) * | 2017-06-14 | 2017-10-17 | 江苏省家禽科学研究所 | The application of oleic acid induction chicken sarcoblast intramuscular fat deposition and abductive approach |
US20200080050A1 (en) * | 2016-07-11 | 2020-03-12 | Yaakov Nahmias | Systems and methods for growing cells in vitro |
-
2022
- 2022-08-12 CN CN202210968300.3A patent/CN117625518B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6835390B1 (en) * | 2000-11-17 | 2004-12-28 | Jon Vein | Method for producing tissue engineered meat for consumption |
US20040038249A1 (en) * | 2001-08-02 | 2004-02-26 | Raphael Darteil | Inducible expression systems employing PPAR transcriptional activators |
US20200080050A1 (en) * | 2016-07-11 | 2020-03-12 | Yaakov Nahmias | Systems and methods for growing cells in vitro |
CN107254434A (en) * | 2017-06-14 | 2017-10-17 | 江苏省家禽科学研究所 | The application of oleic acid induction chicken sarcoblast intramuscular fat deposition and abductive approach |
Non-Patent Citations (6)
Title |
---|
DE COPPI, P. ET AL.: "Rosiglitazone modifies the adipogenic potential of human muscle satellite cells", 《DIABETOLOGIA》, 24 June 2006 (2006-06-24), pages 1962, XP019417869, DOI: 10.1007/s00125-006-0304-6 * |
DONG-HWAN KIM ET AL.: "Adipogenic and Myogenic Potentials of Chicken Embryonic Fibroblasts in vitro: Combination of Fatty Acids and Insulin Induces Adipogenesis", 《LIPIDS》, 13 February 2020 (2020-02-13), pages 163 - 171 * |
TSAGKARAKI, E. ET AL.: "CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease", 《NAT COMMUN》, vol. 12, 26 November 2021 (2021-11-26), pages 11 * |
皇甫一凡: "C/EBPα基因诱导牛成肌细胞转分化的研究", 《中国优秀硕士学位论文全文数据库 农业科技辑》, 15 May 2015 (2015-05-15), pages 6 - 2 * |
赵鑫锐 等: "人造肉生产技术相关专利分析", 《食品与发酵工业》, 17 February 2020 (2020-02-17), pages 299 - 305 * |
陈秀兰,魏荣瑄编著: "《干细胞的魔力从何而来》", 28 February 2015, 福建少年儿童出版社, pages: 26 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118497112A (en) * | 2024-04-30 | 2024-08-16 | 江南大学 | Food-grade adipogenic differentiation inducer for cell-cultured meat |
CN118530938A (en) * | 2024-07-26 | 2024-08-23 | 吉林大学 | An optimized method for promoting adipogenic differentiation of bovine skeletal muscle cells |
CN119020275A (en) * | 2024-10-29 | 2024-11-26 | 中国海洋大学 | Marine fish cell culture fish oil and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN117625518B (en) | 2025-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN117625518A (en) | Method for preparing cell culture snowflake meat | |
Koninckx et al. | Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study | |
Cui et al. | Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation | |
CA2867953C (en) | Regulating stem cells | |
US20110312091A1 (en) | Pluripotent stem cells, method for preparation thereof and uses thereof | |
JP2021090463A (en) | Cell culture method for mesenchymal stem cells | |
EP2539437B1 (en) | SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS | |
CN105267243B (en) | Stem cell extract for eliminating skin striae gravidarum | |
JP2017506511A (en) | Serum-free medium | |
JP2018534934A (en) | Method for inducing differentiation from human induced pluripotent stem cells to Leydig cells and uses thereof | |
US20220135947A1 (en) | Methods for culturing mesenchymal stem cells, products thereof, and applications thereof | |
CN102618497B (en) | Method for preparing retinal pigment epithelia by utilizing human marrow mesenchymal stem cells | |
CN111518751A (en) | A method for in vitro activation of adipose stem cells into primary chondrocytes | |
TW201923071A (en) | Methods for differentiation inducing and producing into beige and white adipocytes | |
CN107674858B (en) | Separation medium and separation method of bone marrow endothelial progenitor cells | |
KR101119225B1 (en) | Large scale production of growth promoting factors using fetus-derived mesenchymal stem cells from amniotic fluids | |
CN117586947A (en) | Methods for co-culture and directed differentiation induction of muscle satellite cells and adipose stem cells | |
CN106282103A (en) | Animal mescenchymal stem cell immunosuppressant can strengthen serum-free medium | |
US9404084B2 (en) | Regulating stem cells | |
Zhang et al. | Isolation and biological characterization of muscle-derived stem cells from sheep skeletal muscle | |
JP2023545340A (en) | Method for in vitro or ex vivo amplification of brown or beige adipocyte stem cells | |
Cebo | Characterization of bovine adipose-derived stem cells | |
Zhang Ping et al. | Isolation and biological characterization of muscle-derived stem cells from sheep skeletal muscle. | |
CN110055216A (en) | A method of improving interstital stem cell biological function | |
CN116004521B (en) | Culture medium for in-vitro proliferation of chicken myogenic stem cells, preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |